Email: anthony.cmelak@vanderbilt.edu

Qualifications

2011 Professor, Vanderbilt University, USA, Radiation Oncology

2002 Associate Professor, Vanderbilt University, USA, Radiation Oncology

1996 Assistant Professor, Vanderbilt University, USA, Radiation Oncology

1996 Residency, Stanford Univerity, USA, Radiation Oncology

1992 M.D., Northwestern University Medical School, USA

1988 B.S., Biological Sciences, U. California at Irvine, USA

Publications (Selected)

1. Cmelak, A. J., Cox R., Adler J., Fee W., Goffinet D. R., Radiosurgery for Skull-Base Recurrences and Nasopharyngeal Carcinoma. International Journal of Radiation Oncology, Biology, Physics. 37(5): p. 997-1003, 1997. (PMID: 9169805)
2. Cmelak, A. J., Kapp, D. S., Long-term Survival with Whole Abdominopelvic Irradiation in Platinum-Refractory Ovarian Cancer. Gynecologic Oncology 65: 453-60, 1997. (PMID: 9190975)
3. Cmelak, A. J., Murphy B. A., Day T., Combined Modality Therapy for Locoregionally Advanced Head and Neck Cancer. Oncology 13(10 Suppl. 5): p. 83-91, 1999. (PMID: 10550831)
4. Cmelak, A. J., Choy H., Shyr Y., Mohr P., Glantz M. J., Johnson D. H., National Survey on Prophylactic Cranial Irradiation, Differences in Practice Patterns Between Medical and Radiation Oncologists. Int. J. Rad. Oncol. Bio. Phys., 44(1), p. 157-162, 1999. (PMID, 10219809)
5. Choy H., Shyr Y., Cmelak, A. J., Mohr P., Johnson D. H., Patterns of Practice Survey for Non-Small Cell Lung Cancer in the U. S. Cancer, 88(6), 1336-1346, 2000. (PMID, 10717614)
6. Hallahan D., Geng L., Cmelak A., Chakravarthy B. A., Scarfone C., Gonzalez A., Targeting Drug Delivery to Radiation-Induced Neoantigens in Tumor Microvasculature. Control Release, 74(1-3), 183-191, 2001. (PMID, 11489494)
7. Cmelak, A. J., Abou-Khalil B., Konrad P. E., Duggan D., Maciunas R. J., Stereotactic Radiosurgery for Medically-Intractable Mesial Temporal Lobe Epilepsy, A Case Report. Seizure. 2001 Sep 10(6), 442-6. (PMID, 11701000)
8. Schefter J. K., Allen G., Cmelak, A. J., Johnson M., Toms S., Duggan D., Blevins L. S., The Utility of External Beam Irradiation and Intracystic ³²P Radiation in the Treatment of Craniopharyngiomas. Journal of Neuro-Oncology 56, 69-78, 2002. (PMID, 11949829)
9. Jennings M. T., Cartwright J., Cmelak A., Helton K. J., Johnson M. D., Maciunas R., Martincic D., Moots P., Pais R., Shyr Y., Tulipan N., Whitlock J. A., Differential Responsiveness to ‘High Risk’ Pediatric Brain Tumors to Dose-Intensive Induction Chemotherapy and Hyperfractionated Radiotherapy. Pediatric Blood Cancer July, 43(1), 46-54, 2004.
10. Cmelak, A. J., Barbara A., Murphy B. A., Burkey B., Douglas S., Netterville J., Taxane-Based Chemoradiation for Organ Preservation with Locally-Advanced Head and Neck Cancer, Results of a Phase II Multi-Institutional Trial. Head Neck Jan., 24, 2006.
11. Murphy, B. A., Cmelak A., Chemoradiation Therapy, The Evolving Role in Head and Neck Cancer and Its Application to Oral Cavity Tumors. Oral Maxillofacial Surg Clin of N Am 18 (4), 605-614, 2006. (PMID, 18088855)
12. Cmelak, A. J., Murphy, B. A., Burkey B., Douglas S., Netterville J., Taxane-Based Chemoradiation for Organ Preservation with Locally-Advanced Head and Neck Cancer, Results of a Phase II Trial. Head Neck. 2007 Apr., 29(4), 315-24. (PMID, 17252600)
13. Cmelak, A. J., Li S, Murphy B., Burkey B., Adams G. L., Cannon M., Pinto H., Rosenthal D. I., Ridge J. A., Forastiere A. A., Locally Advanced Resectable Larynx (L) or Oropharynx (OP) Cancer, Results of Phase II Organ Preservation Trial E2399. J. Clin. Oncol., 2007 Sep. 1, 25(25), 3971-7. (PMID, 17761982)
14. Gilbert J., Cmelak A., Shyr Y., Netterville J., Burkey B., Chung C. H., Sinard R., Yarbrough W., Murphy, B. A., Phase II Trial of Irinotecan Plus Cisplatin in Patients with Recurrent or Metastatic Squamous Carcinoma of the Head and Neck. Cancer. 2008 Jul., 1, 113(1), 186-92. (PMID, 18484593)
15. Cmelak, A. J., Lordick F., Borner M., Goldberg R. M., Saif M. W., The US and the EU perspective, Clinical Manifestation, Diagnosis, Grading, and Management of IRs in Clinical Trials and Beyond. Oncology, Mar., 13, 2009, 23(2 suppl. 1) pp18-25. (PMID, 19385160)
16. Cmelak, A. J., Goldberg R., Infusion Reactions Associated with Monocloncal Antibodies in Patients With Solid Tumors. Oncology, Mar., 13, 2009, 23(2 suppl 1), pp5-6. (PMID, 19386548)
17. Cmelak, A. J., Current Issues in Combined Modality Therapy in Locally Advanced Head and Neck Cancer. Am. J. Clin. Oncol., 2012, May 15. (PMID, 22595517)
18. Cmelak, A. J., Arneson A., Chau N. G., Gilbert R. W., Haddad R. I., Locally Advanced Head and Neck Cancer. Am. Soc. Clin. Oncol. Educ., Book. 2013, 237-244. (PMID, 23714512)
19. Pfister D. G., Ang K. K., Brizel D. M., Burtness B. A., Cmelak, A. J., Colevas A. D., Dunphy F., Eisele D. W., Gilbert J., Gillison M. L., Haddad R. I., Haughey B. H., Hicks WL Jr., Hitchcock Y. J., Kies M. S., Lydiatt W. M., Maghami E., Martins R., McCaffrey T., Mittal B. B., Pinto H. A., Ridge J. A., Samant S., Sanguineti G., Schuller D. E., Shah J. P., Spencer S., Trotti A. 3rd, Weber R. S., Wolf G. T., Worden F., Head and Neck Cancers. J. Natl. Compr. Canc. Netw., 2013, May 1, 9(6), 596-650. (PMID, 23946171)
20. Vlacich G., Diaz R., Cmelak, A. J., Gastrostomy Tube Dependency as a Function of IMRT Dose to Pharyngeal Constrictors. Radiother Oncol., 2014, Jan. 15. (PMID, 24440043)
21. Arneson K., Mondschein J., Cmelak, A. J., Niermann K., Attia A., Horn L., Puzanov I., Chakravarthy A. B., Xia F., A Phase I Trial of Concurrent Sorafenib and Stereotactic Radiosurgery for Patients with 1-4 Brain Metastases. Submitted to Int. J. Radiat. Oncol. Biol. Phys., April, 2014.
22. Jackson L. K., Ridner S. H., Deng J., Bartow C., Mannion K., Niermann K., Gilbert J., Dietrich M. S., Cmelak, A. J., Murphy, B. A., Internal lymphedema correlates with subjective and objective measures of dysphagia in head and neck cancer patients. Submitted to Int. J. Radiat. Oncol. Biol. Phys., July, 2014.

Profile Details

http://www.vicc.org/dd/display.php?person=anthony.cmelak